InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the detailed record of transactions filed by Posner Christopher, Chairman & CEO. Director active across 1 companies, notably Cara Therapeutics, Inc.. Aggregated, 6 reports have been logged. Total volume traded: €23k. The latest transaction was filed on 4 April 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€23,1562,006 shares@ €11.5435100.0% of flow
Common Stock
SEC:0001209191-22-023237:0·
039,000 shares0
Common Stock
SEC:0001209191-22-013988:0·
05,941 shares0
Common Stock
SEC:0001209191-21-062593·
05,941 shares0
Common Stock
SEC:0001209191-21-062593:0·
07,200 shares0
Common Stock
SEC:0001209191-21-038764·
07,200 shares0
Common Stock
SEC:0001209191-21-038764:0·
6 of 6 declarations
About Posner Christopher
Christopher Posner is President and CEO of Cara Therapeutics, Inc. In this role, he oversees all operations of the company and ensures performance objectives are met. His expertise in the biopharmaceutical sector is essential for the development of Cara.
